<DOC>
	<DOCNO>NCT02943707</DOCNO>
	<brief_summary>This study evaluate effect autologous bone marrow stem cell infusion ( ABMSCi ) therapy liver diseases.Treatment group receive ABMSCi drug therapy , control group receive drug therapy .</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cells Infusion Treatment Liver Diseases .</brief_title>
	<detailed_description>1 . Autologous bone marrow stem cell ( ABMSC ) mobilization harvest For harvest ABMSC , ABMSC mobilization induce recombinant human granulocyte colony stimulate factor ( rhGCSF , Gran○R ) , administer subcutaneously dose 300μg daily three consecutive day bone marrow puncture . Bone marrow ( 160-200ml ) patient harvest posterior superior iliacs accord standard procedure local anaesthesia collect plastic bag contain heparin . 2 . Both treatment group control group receive drug therapy . 3 . ABMSC separation infusion ABMSC separate purified class 10,000 clean laboratory . After fat bony particle remove filtration , collect cell move cell-processing device . The reagent adopt method negative cell collection . Take cell intend remove target cell , carry removal step-by-step . On basis method , red blood cell , blood platelet , blood plasma completely remove part white cell lymphocytes remarkably remove well stem cell / progenitor cell well retain . The nucleated cell ( white blood cell ) count final ABMSC measure automate complete blood count instrument flow cytometry analysis . The number mononuclear cell count manually microscope Wright-Giemsa stain method . Cell differentiation factor 34 ( CD34 ) positive cell determine flow cytometry analysis . The time ABMSC separation purification 2.5-3 hour . ABMSC add 10 ml saline well mixed shake vial gently . The catheter push reach proper hepatic artery . The diameter catheter 1.4mm , thin enough easily insert right gastric artery . The mixture saline ABMSC infuse proper hepatic artery uniform speed two minute . The catheter remove ABMSCi . 4 . Statistical analysis - Categorical data present absolute value percentage , whereas continuous data summarize mean Standard Deviation . Statistical analysis perform use t-test pair unpaired sample . Time course measurement liver function parameter analyze repeated-measures ANOVA . The analysis perform use Statistic Package Social Science ( SPSS ) . All statistical analysis base two-tailed hypothesis test significance level p &lt; 0.05 .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>1 . Definite liver disease ( viral hepatitis , autoimmune liver disease , fatty liver disease , ect ) ; 2 . Active bone marrow hyperplasia show bone marrow biopsy ABMSCi ; 3 . Age 18 60 year ; 4 . Abnormal liver function . 1 . Enlisted liver transplantation 2 . Diagnosis hepatocellular carcinoma cancer 3 . Other severe medical disease , acute infection 4. pregnant nursing female , coinfections HIV , serious bacterial infection 5. vital organ system dysfunction 6. severe complication liver cirrhosis 7. hematological disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>liver disease</keyword>
	<keyword>Bone Marrow Cell Transplantation</keyword>
</DOC>